<DOC>
	<DOCNO>NCT02548455</DOCNO>
	<brief_summary>The primary intent study assess safety model 1457Q Quartet Left Ventricular ( LV ) lead 3 month patient population indicate cardiac resynchronization therapy .</brief_summary>
	<brief_title>St Jude Medical LV Lead - Quartet 1457Q IDE</brief_title>
	<detailed_description>This prospective , multi-center , IDE clinical study design evaluate safety Model 1457Q Quartet LV lead . A minimum 94 maximum 430 subject enrol study 40 center worldwide . All subject successfully implant Quartet 1457Q lead follow every 6 month post implant Pre Market Approval ( PMA ) obtain study close . After complete participation IDE study , subject continue participation post-approval study , return follow visit every 6 month post implant 5 year follow visit post implant complete .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<criteria>1 . Meets current SJM clinical indication implantation CRT system : `` provide reduction symptom moderate severe heart failure ( New York Heart Association Functional Class III IV ) patient remain symptomatic despite stable , optimal medical therapy leave ventricular ejection fraction â‰¤ 35 % prolonged QRS duration , OR `` maintain synchrony leave right ventricle patient undergone Atrio Ventricular nodal ablation chronic ( permanent ) atrial fibrillation New York Heart Association Functional Class II III heart failure . 2 . Is receive new marketapproved SJM Quadripolar CRT system implant Model 1457Q Quartet LV lead . 3 . Have ability provide inform consent study participation willing able comply prescribe followup test schedule evaluation . 4 . Are 18 year , legal age give inform consent specific state national law . 1 . Had previous unsuccessful commercial nonQuartet 1457Q LV lead implant attempt 2 . Have hypersensitivity single 1.0mg dose dexamethasone sodium phosphate 3 . Patient currently participate plan participate potentially confound drug device trial course study . Coenrollment study may allow preapproval grant study manager . 4 . Are pregnant plan pregnancy next 6 month 5 . Have life expectancy le 24 month due condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>